XT
SWTX

XTX Topco’s SpringWorks Therapeutics SWTX Stock Holding History

XTX Topco’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35,027
Closed -$1.55M – 3142
2025
Q1 		$1.55M Buy
+35,027
New +$1.61M 0.08% 346
2024
Q4 		– Sell
-8,997
Closed -$288K – 2912
2024
Q3 		$288K Sell
8,997
-7,494
-45% -$280K 0.02% 1213
2024
Q2 		$621K Buy
+16,491
New +$694K 0.05% 551
2022
Q4 		– Sell
-7,135
Closed -$204K – 1493
2022
Q3 		$204K Buy
+7,135
New +$205K 0.05% 767
2022
Q1 		– Sell
-4,736
Closed -$294K – 940
2021
Q4 		$294K Buy
+4,736
New +$313K 0.17% 211
2021
Q3 		– Sell
-2,994
Closed -$247K – 1045
2021
Q2 		$247K Buy
+2,994
New +$227K 0.08% 463

Other funds holding SWTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

XTX Topco's SWTX Position: Q2 2025 in Review

XTX Topco sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 35,027 shares — an estimated $1.55M sold.

XTX Topco first reported a position in SWTX in Q2 2021 and held it in 6 quarters. The position peaked at $1.55M in Q1 2025. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • XTX Topco reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • XTX Topco sold 35,027 SpringWorks Therapeutics shares in Q2 2025, an estimated $1.55M.
  • XTX Topco first reported a position in SpringWorks Therapeutics in Q2 2021 and held it in 6 quarters.
  • XTX Topco's SpringWorks Therapeutics position peaked at $1.55M in Q1 2025.
  • 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.